- Global Pharma News & Resources

PTA Balloon Catheter Market To Surpass US$ 2,038.6 Million by 2026, At a CAGR of 6.8% | Exclusive Report by Coherent Market Insights

Rising prevalence of urological and cardiovascular diseases is expected to drive growth of the PTA balloon catheter market

The global PTA balloon catheter market growth is driven is by rising number of cardiovascular diseases and urological diseases. Moreover, the market growth is fueled by rising number of strategies such as product approvals, product launches, and mergers and acquisitions adopted by players in the market. For instance, in November 2015,  SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitrodiagnostic technologies, announced that it acquired Creagh Medical Ltd., an innovative developer and manufacturer of percutaneous transluminal angioplasty (PTA) balloon catheters. Through this acquisition, SurModics will move a step forward in its strategy to transform its medical device business from being a provider of coating technologies, to offering whole-product solutions to medical device customers in the large and growing global interventional vascular market.

For instance, in December 2016, BrosMed announced the U.S FDA 510(k) clearance and launch of its Hermes NC 0.035 OTW PTA, Achilles NC 0.018 OTW PTA, and Castor NC 0.014 OTW PTA balloon dilatation catheter for the treatment of patients with peripheral arterial diseases. Furthermore, in April 2019, Becton, Dickinson and Company announced the launch of UltraScore 014 focused force percutaneous transluminal angioplasty (PTA) balloon. The UltraScore balloon is intended to dilate stenoses in the iliac, femoral, ilio-femoral, popliteal, infra-popliteal and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.

However, few class 1 recalls have been identified by the FDA. The use of these devices could cause serious injuries or death. This is expected to hamper the market growth. For instance, in May 2019, Cook Medical recalled the Advance Enforcer 35 Focal Force PTA balloon catheter due to the balloon bursting below the rated burst pressure.

Request for Sample Copy of Report:

Furthermore, high potency PTA balloon catheter are expected to provide manufacturers with growth opportunity and rising demand for angioplasty surgery is expected to fuel growth of the PTA balloon catheter market growth. Moreover, in December 2017, iVascular announced the release of new Oceanus 14 Pro PTA balloon catheter, which received CE mark approval to dilate stenoses in femoral, popliteal, and infrapopliteal arteries, and for the treatment of obstructive lesions in arteriovenous dialysis fistulae.

Key Takeaways of the PTA balloon catheter Market:

  • The global PTA balloon catheter market is expected to exhibit a CAGR of 6.8% over the forecast period. This growth is attributed to rising demand for high potency PTA balloon catheters, increasing demand for PTA balloon catheter manufacturing, and rising prevalence of cardiovascular disease.
  • Among application, peripheral vascular disease segment held dominant position in the PTA balloon catheter market in 2018, as there are a broad range of peripheral vascular applications. For instance, in May 2018, Surmodics Inc., a provider of medical device and in-vitrodiagnostic technologies, received the U.S. Food and Drug Administration (FDA) 510(k) clearance for its .018-inch low-profile percutaneous transluminal angioplasty (PTA) balloon dilation catheter, designed and indicated for a broad range of peripheral vascular applications.
  • Some of the key players operating in the global PTA balloon catheter market include Medtronic, Terumo, Cardinal Health, Boston Scientific, AndraTec, Cook Medical, Biotronik, Abbott, Creagh Medical, TriReme Medical, and Natec Medical.


Buy-Now this research report:

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 28-Sep-2021